
Helping biotech companies translate innovative therapeutics into clinical reality
I am Catherine Owczarek, an independent biotechnology consultant with more than 20 years of experience spanning therapeutic discovery, translational strategy and development planning.
I work with biotechnology companies to translate promising science into development programmes, helping teams define pathways to the clinic, identify key risks and opportunities, and make informed decisions at critical stages of programme development.

How I support biotech companies developing human therapeutics
01
Development Planning & Nonclinical Strategy
Defining practical development pathways, identifying evidence gaps and helping translate promising therapeutic science into structured, development-ready programmes.
02
Preclinical Studies & External Partnerships
Working with CROs, academic collaborators and specialist providers to ensure development activities address key scientific questions and generate data that supports informed decisions.
03
Scientific & Translational Support
Integrating scientific, translational and regulatory considerations to support study design, data interpretation and progression toward clinical development.
04
Scientific Knowledge & Information Management
Helping organisations organise scientific knowledge, data and development information to support traceability, informed decision-making, knowledge retention and long-term programme value.

ABOUT CATHERINE
Bringing translational strategy and development planning together
My career has spanned more than two decades across CSL and the biotechnology sector, helping organisations translate promising science into therapeutic development programmes.
My experience includes therapeutic discovery, translational strategy, preclinical development, development planning, laboratory informatics and external partnering. I have worked with teams ranging from early-stage biotechnology companies to global organisations, helping define development pathways, prioritise activities, manage risk and support key decision-making.
Whether developing a therapeutic programme, coordinating external studies, implementing scientific information systems or planning development activities, my focus is on helping organisations make informed decisions based on robust science, accessible knowledge and clearly defined development objectives.
I work collaboratively with clients to navigate scientific and development challenges while maintaining momentum towards clinical development.
01
Translational Strategy
Evaluating scientific opportunities, identifying key development risks and defining practical pathways to advance therapeutic programmes toward clinical development.
Experience and Capabilities
Supporting nonclinical and translational development programmes by bringing structure, clarity and scientific rigour to development planning and decision-making.
02
Nonclinical Development Planning
Supporting study planning, prioritisation and evidence-based decision-making to ensure key scientific questions are addressed and programmes progress efficiently toward development milestones.
03
Preclinical Studies & External Partnerships
Supporting the design and review of preclinical studies, and working with CROs, academic collaborators and specialist providers to generate data that informs key development decisions.
Let's discuss what's next
Whether you need support with nonclinical development planning, scientific strategy, study review, external partnerships or development decision-making, I can help bring clarity to complex development challenges.
To get in touch complete the form below or contact me directly using the details provided.
